Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Severstal started production of cryogenic valves for first time in Russia

8/28/23 CHMF

Acron reported for 6 months 2023 by IFRS

8/28/23 AKRN

Lenta increased sales thanks to Zoomarkets

8/28/23 LENT

VK will get more than 90% in Tetrica's education platform

8/28/23 VKCO

TMK reported for 6 months of 2023 by IFRS

8/28/23 TRMK

SuperJet International wants a European certificate for the SSJ 100

8/28/23 UNAC

Volgogradenergosbyt reported for 6 months of 2023 by IFRS

8/28/23 VGSB

NPO Nauka reported for 6 months of 2023 by IFRS

8/28/23 NAUK

Nauka-Svyaz reported for 6 months of 2023 by IFRS

8/28/23 NSVZ

RSC Energia reported for 6 months of 2023 by IFRS

8/28/23 RKKE